Shell Asset Management Co. reduced its stake in shares of Clorox Co (NYSE:CLX) by 4.2% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 48,838 shares of the company’s stock after selling 2,159 shares during the quarter. Shell Asset Management Co.’s holdings in Clorox were worth $8,461,000 at the end of the most recent quarter.
A number of other large investors also recently added to or reduced their stakes in CLX. Wealth Quarterback LLC acquired a new position in shares of Clorox in the 4th quarter valued at $18,905,411,000. Norges Bank acquired a new position in shares of Clorox in the 4th quarter valued at $184,037,000. BlackRock Inc. raised its stake in shares of Clorox by 8.1% in the 1st quarter. BlackRock Inc. now owns 11,551,578 shares of the company’s stock valued at $2,001,312,000 after buying an additional 866,360 shares in the last quarter. Victory Capital Management Inc. raised its stake in shares of Clorox by 46.4% in the 4th quarter. Victory Capital Management Inc. now owns 1,640,639 shares of the company’s stock valued at $258,089,000 after buying an additional 520,194 shares in the last quarter. Finally, Parnassus Investments CA raised its stake in shares of Clorox by 8.6% in the 4th quarter. Parnassus Investments CA now owns 5,049,429 shares of the company’s stock valued at $775,289,000 after buying an additional 397,930 shares in the last quarter. Hedge funds and other institutional investors own 76.45% of the company’s stock.
A number of equities analysts have recently issued reports on CLX shares. UBS Group increased their price objective on shares of Clorox from $155.00 to $168.00 and gave the company a “sell” rating in a research note on Monday, May 4th. Morgan Stanley increased their price objective on shares of Clorox from $173.00 to $177.00 and gave the company an “underweight” rating in a research note on Monday, May 4th. Argus upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $195.00 target price for the company in a research report on Monday, March 9th. Cfra increased their target price on shares of Clorox from $170.00 to $190.00 and gave the stock a “hold” rating in a research report on Friday, May 1st. Finally, Royal Bank of Canada reiterated a “hold” rating and set a $195.00 target price on shares of Clorox in a research report on Tuesday, April 14th. Three equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company. Clorox currently has an average rating of “Hold” and an average target price of $173.23.
NYSE:CLX traded down $0.81 during mid-day trading on Friday, reaching $198.59. 1,213,707 shares of the company were exchanged, compared to its average volume of 2,024,068. Clorox Co has a 12 month low of $144.12 and a 12 month high of $214.26. The company has a fifty day moving average of $193.16 and a 200 day moving average of $167.10. The company has a quick ratio of 0.72, a current ratio of 0.98 and a debt-to-equity ratio of 3.69. The stock has a market cap of $25.11 billion, a PE ratio of 29.12, a PEG ratio of 5.01 and a beta of 0.24.
Clorox (NYSE:CLX) last issued its quarterly earnings data on Friday, May 1st. The company reported $1.89 EPS for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. Clorox had a net margin of 13.67% and a return on equity of 147.52%. The firm had revenue of $1.78 billion for the quarter, compared to analyst estimates of $1.69 billion. During the same quarter in the prior year, the firm earned $1.44 EPS. The company’s revenue was up 15.0% on a year-over-year basis. On average, equities research analysts anticipate that Clorox Co will post 6.89 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Wednesday, July 29th will be issued a dividend of $1.11 per share. The ex-dividend date is Tuesday, July 28th. This represents a $4.44 dividend on an annualized basis and a yield of 2.24%. This is a positive change from Clorox’s previous quarterly dividend of $1.06. Clorox’s dividend payout ratio is currently 67.09%.
In other news, SVP Denise Garner sold 870 shares of the firm’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $170.00, for a total value of $147,900.00. Following the transaction, the senior vice president now owns 50,489 shares of the company’s stock, valued at approximately $8,583,130. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP William S. Bailey sold 7,969 shares of the firm’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $207.53, for a total transaction of $1,653,806.57. Following the completion of the transaction, the senior vice president now directly owns 15,172 shares in the company, valued at approximately $3,148,645.16. The disclosure for this sale can be found here. In the last three months, insiders have sold 300,843 shares of company stock worth $52,556,301. Insiders own 1.14% of the company’s stock.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Further Reading: Backdoor Roth IRA Conversion and Strategy
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.